Artemisia Outgrowing - Madagascar

Topic: Artemisia Outgrowing

Client: Bionexx SA


Synopsis: Bionexx SA is a very innovative company that produces artemisinin, an ingredient in artemisinin-based combination therapy malaria medication.

Our role: To improve the quantity and quality of the anti-malaria medication, the company needed to increase their out growers base from 10K to 25K people as well as invest in several machinery. DIBcoop drafted the concept note and the proposal was immediately accepted by the funding organisation. DIBcoop thereafter lead the lengthy application process until fund were disbursed. 


Amount raised:  EU € 1.5 million

Fund type: Loan (5.5% interest rate)

Fund Organisation: Common Fund for Commodities